Malaysia's state energy giant Petronas unveils a sweeping three-year plan to sustain domestic oil and gas output, expand its global LNG footprint, and position itself as a regional leader in carbon capture, navigating the complex transition toward a lower-carbon future.
A deep dive into Pantech Group Holdings Berhad's valuation using a Discounted Cash Flow model suggests the stock may be trading close to its intrinsic value, offering investors a potential entry point in the industrial supplies sector.
As UPS announces a major workforce reduction linked to its Amazon partnership, investors are weighing the logistics giant's strategic pivot against its hefty 6% dividend yield. The move underscores a broader industry recalibration for profitability in a changing delivery landscape.
Lemonade's stock soared in January, propelled by the launch of a novel, usage-based insurance plan for Tesla vehicles that slashes premiums when Full Self-Driving is engaged, signaling a strategic pivot towards data-driven, autonomous future.
Shares of CTI Logistics Limited (ASX:CLX) have climbed 25% in the past three months, prompting a closer look at the company's fundamentals. While its Return on Equity appears modest, exceptional earnings growth and a consistent dividend history suggest underlying strength.
Faced with mounting debt, Houston's Nine Energy Service has filed for a prepackaged Chapter 11 bankruptcy. The company, which will continue operations, has secured new financing and plans a major financial restructuring agreed upon with key lenders.
The explosive growth of artificial intelligence and data centers is driving U.S. electricity demand to unprecedented levels, pushing consumer bills up 42% in a decade. As utilities scramble to upgrade an overburdened grid, AI itself is emerging as a critical tool to unlock next-generation power sources like fusion and geothermal energy.
A tentative détente between the U.S. and Iran is injecting optimism into Gulf markets, with bourses in Saudi Arabia and Dubai rallying. Against this backdrop, investors are scouring the region for fundamentally strong companies poised to capitalize on the shifting landscape.
Despite a respectable return on capital, Coles Group's flat performance over five years signals a mature business in a holding pattern, leading investors to question its long-term compounding potential.
A notable easing of US-Iran tensions has buoyed investor confidence across Gulf bourses, creating a favorable backdrop for stable, income-generating equities. We analyze three regional dividend stocks offering potential portfolio resilience amid shifting market dynamics.
Azenta, Inc. is set to report its quarterly earnings before the market opens Wednesday. Analysts project stagnant year-over-year revenue, placing the spotlight on the company's ability to navigate a challenging market for life sciences tools and services.
As Steris prepares to report its fiscal fourth-quarter results, investors are watching to see if the company can maintain its recent streak of topping revenue estimates against a backdrop of mixed signals from the broader healthcare equipment sector.
CME Group is set to report fourth-quarter earnings Wednesday morning, with analysts forecasting a 7.8% revenue increase. The derivatives exchange operator's performance may signal broader capital markets health as peers post mixed results.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Arcellx shares have delivered stellar multi-year gains, prompting investors to question if the rally still has room to run. A deep dive into valuation metrics reveals a complex picture, with discounted cash flow models pointing to significant upside while price-to-book ratios suggest a more cautious stance.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
Amgen has terminated its collaboration with Kyowa Kirin on the atopic dermatitis drug rocatinlimab, handing full development rights back to the Japanese partner. The strategic shift comes as Amgen's stock trades above most fair value estimates, raising questions about its current valuation amid pipeline recalibration.
Shares of Coastal Financial (CCB) have tumbled over 13% in the past month, sparking debate among investors. While a proprietary valuation model suggests the stock is deeply undervalued, its premium P/E ratio tells a conflicting story. We examine the numbers and the broader context for regional banks.
Stanley Black & Decker announces key leadership changes, appointing a new General Counsel and adding fresh expertise to its board. The moves signal a deeper focus on governance and operational oversight as the company navigates its financial turnaround.
Kemper Corporation is set to report its fourth-quarter earnings Wednesday afternoon, with investors watching closely for signs of stability after a period of mixed performance and sector-wide pressure.
